Lanzamiento Enero 2027

Ensayo controlado aleatorizado2017

Effects of Cholecalciferol vs Calcifediol on Total and Free 25-Hydroxyvitamin D and Parathyroid Hormone

Shieh A, Ma C, Chun RF, Witzel S, Rafison B, Contreras HTM, Wittwer-Schegg J, Swinkels L, Huijs T, Hewison M, Adams JS

The Journal of clinical endocrinology and metabolism · 40 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Gobierno
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Gobierno
National Center for Advancing Translational Sciences
Gobierno
NCATS NIH HHS
Gobierno
NIAMS NIH HHS
Subvenciones
National Center for Advancing Translational Sciences (UL-1TR000124); National Institute of Arthritis and Musculoskeletal and Skin Diseases (R21 AR073018); National Institute of Arthritis and Musculoskeletal and Skin Diseases (P50AR063020); National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR063910)

Según 4 financiadores declarados.

Publicación

Publicado
2017-02-10 · J Clin Endocrinol Metab · vol. 102 · número 4 · págs. 1133–1140
Editorial
Oxford University Press
Citado
58 citas · más que el 93% de estudios similares · 3.5× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
45 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Vitamin D Research Studies · Parathyroid Disorders and Treatments · Thyroid Disorders and Treatments
Palabras clave
Cholecalciferol, Calcifediol, Parathyroid hormone, Vitamin D and neurology, Internal medicine, Endocrinology, Medicine, vitamin D deficiency, Calcium
MeSH
humans, vitamin d deficiency, calcium, cholecalciferol, calcifediol, parathyroid hormone, vitamin d, adult, middle aged, female, male, young adult

11 autores

  • Albert Shieh
  • Christina Ma🇺🇸University of California, Los Angeles
  • Rene F. Chun
  • Sten de Boom Witzel
  • Brandon Rafison
  • Hannah T. M. Contreras
  • Jonas Wittwer-Schegg🇨🇭DSM (Switzerland)
  • L M Swinkels🇳🇱Future Diagnostics (Netherlands)
  • Tonnie Huijs🇳🇱Future Diagnostics (Netherlands)
  • Martin Hewison🇬🇧University of Birmingham
  • John S. Adams

Resumen

El texto original del estudio, en el idioma en que se publicó.

Context

Vitamin D deficiency disproportionately affects nonwhite individuals. Controversy persists over how to best restore low 25D levels, and how to best define vitamin D status [total (protein bound plus free) vs free 25D].

Objective

To assess the effects of vitamin D3 (cholecalciferol, or D3) vs 25-hydroxyvitamin D3 (calcifediol, or 25D3) on total and free 25D in a multiethnic cohort of adults, and whether change in parathyroid hormone (PTH) is more strongly associated with total vs free 25D.

Design

Sixteen-week randomized controlled trial. Biochemistries at 0, 4, 8, and 16 weeks.

Setting

Academic medical center.

Participants

Thirty-five adults ≥18 years of age with 25D levels <20 ng/mL.

Intervention

Sixty micrograms (2400 IU)/d of D3 or 20 μg/d of 25D3.

Main outcome measures

Total and free 25D, and PTH.

Results

Baseline total (16.2 ± 3.7 vs 17.0 ± 2.5 ng/mL; P = 0.4) and free (4.2 ± 0.8 vs 4.7 ± 1.0 pg/mL; P = 0.2) 25D were similar between D3 and 25D3 groups, respectively; 25D3 increased total (+25.5 vs +13.8 ng/mL; P = 0.001) and free (+6.6 vs +3.5 pg/mL; P = 0.03) 25D more than D3. By 4 weeks, 87.5% of 25D3 participants had total 25D levels ≥30 ng/mL, compared with 23.1% of D3 participants (P = 0.001). Change in PTH was associated with both total (P = 0.01) and free 25D (P = 0.04).

Conclusions

25D3 increased total and free 25D levels more rapidly than D3, regardless of race/ethnicity. Free and total 25D were similarly associated with change in PTH.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.